InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Lee Gary K.. Officer active across 1 company, notably Lyell Immunopharma, Inc.. Cumulatively, 9 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €57k. History available since 9 February 2024. The latest transaction was disclosed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Lee Gary K. is a declarant linked to Lyell Immunopharma, Inc., where he is Chief Scientific Officer. The 8 filings recorded in the recent sample run from 2024-02-13 to 2026-08-11, with EUR 37617 of sales and EUR 0 of purchases; the modal transaction nature is sale.